cancer therapy II (4SC)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Namecancer therapy II (4SC)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator Companies4sc Ag

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies4sc Ag

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A